Moderna CEO Says Its Coronavirus Vaccine Will Be Affordable

As the COVID-19 epidemic continues to spread, demand keeps growing for effective treatments and vaccines. Moderna (NASDAQ:MRNA), one of the only companies with a vaccine in clinical trials for SARS-CoV-2 (the coronavirus that causes the disease), made news Wednesday when its CEO said that his company's vaccine would be affordably priced.